Delivery Order SPE2DB20D2014-SPE2DB25FC87V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $1,605.44 and an ultimate completion date of October 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Troop Support Medical awarded a $14,290.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mg vials of ryanodex. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 7, 2023 through September 25, 2023. No major subcontractors or set aside designations were indicated. This delivery order appears to be fulfilling a...
- The U.S. Defense Medical Supply Chain awarded a $52,979.52 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price delivery order is set to conclude on August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a $1,605.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,605.44 delivery order to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. This firm fixed-price contract, which was not set-aside and competitively awarded, is scheduled for completion by October 8, 2025. Ryanodex (dantrolene sodium) is a rapid-onset muscle relaxant used in acute medical settings, particularly for malignant hyperthermia management in military and veteran healthcare systems. The product will be performed and shipped...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,210.88 by the Defense Logistics Agency's Medical Supply Chain on May 14, 2025, for the supply of Ryanodex 250 mg vials. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 5, 2025. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $6,421.76 firm fixed-price delivery order for 250 mg vials of Ryanodex, a muscle relaxant used primarily in anesthesia and critical care settings. This non-competitive delivery order, issued on June 20, 2025, with an ultimate completion date of July 14, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ryanodex 250mg vials with a firm fixed price ceiling value of $57,795.84 and an ultimate completion date of August 18, 2025. This is a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,816.32 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 13, 2025, with performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for 250 mg vials of the drug Ryanodex, with a ceiling value of $5,716.40. The order was awarded on April 12, 2023 and has a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC87VDelivery Order
The Defense Logistics Agency awarded a $9,632.64 delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials under a firm fixed price contract. The award was announced on September 2, 2025, with an ultimate completion date of September 23, 2025. This delivery order carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Ryanodex, a dantrolene sodium preparation used in the treatment of malignant hyperthermia, represents part of the specialized medication portfolio the company delivers to support Defense Health Agency and other federal healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 9/2/25 |